Viewing Study NCT07281118


Ignite Creation Date: 2025-12-25 @ 4:33 AM
Ignite Modification Date: 2025-12-26 @ 3:35 AM
Study NCT ID: NCT07281118
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-15
First Post: 2025-12-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Intercostal Cryoanalgesia in Double Lung Transplant Recipients
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D000377', 'term': 'Agnosia'}], 'ancestors': [{'id': 'D010468', 'term': 'Perceptual Disorders'}, {'id': 'D019954', 'term': 'Neurobehavioral Manifestations'}, {'id': 'D009461', 'term': 'Neurologic Manifestations'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D017679', 'term': 'Cryotherapy'}], 'ancestors': [{'id': 'D013812', 'term': 'Therapeutics'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER']}, 'primaryPurpose': 'SUPPORTIVE_CARE', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 148}}, 'statusModule': {'overallStatus': 'NOT_YET_RECRUITING', 'startDateStruct': {'date': '2026-01-05', 'type': 'ESTIMATED'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-12', 'completionDateStruct': {'date': '2027-11-24', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-12-10', 'studyFirstSubmitDate': '2025-12-01', 'studyFirstSubmitQcDate': '2025-12-10', 'lastUpdatePostDateStruct': {'date': '2025-12-15', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2025-12-15', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2027-11-24', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Total opioid use (oral morphine equivalents)', 'timeFrame': '1 year', 'description': 'Total opioid use (oral morphine equivalents)'}], 'secondaryOutcomes': [{'measure': 'Frequency of rescue therapy', 'timeFrame': '1 year', 'description': 'Compare need for thoracic epidural anesthesia.'}, {'measure': 'Median daily pain score', 'timeFrame': 'Day 10', 'description': 'To compare the Median daily pain score for the first 10 days after lung transplantation, Numerical Rating Scale (NRS) (0-10): A standard 11-point scale (0=no pain, 10=worst imaginable pain) used for pain intensity, showing good reliability and validity in various conditions like neuropathic pain.'}, {'measure': 'Duration of ICU Stay', 'timeFrame': 'Days 1-10, 30 days, 60 days', 'description': 'To compare the duration of the ICU stay'}]}, 'oversightModule': {'isUsExport': False, 'oversightHasDmc': True, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': True}, 'conditionsModule': {'keywords': ['Lung Transplant', 'Pain Management'], 'conditions': ['Post-operative Pain Management']}, 'descriptionModule': {'briefSummary': 'This study is testing a new way to help manage pain after a double lung transplant. Instead of relying only on strong pain medicines like opioids, doctors will use a cold-therapy probe during surgery to help numb the nerves near the incision. Researchers want to see if this method can reduce the need for opioids and improve recovery.', 'detailedDescription': 'This study is being done to learn whether a special cold-therapy treatment can help control pain after a double lung transplant. During the surgery, doctors may use a device called the Atricure CryoSPHERE MAX Probe, which gently freezes the nerves around the incision to reduce pain for several days. This freezing effect may help patients need fewer opioid pain medicines, which can sometimes cause sleepiness or make it harder to breathe deeply after surgery. Researchers will compare patients who receive the cryotherapy treatment to patients who receive the usual care without the device.\n\nThe main goal is to see whether the cryotherapy group uses at least 25% fewer opioids in the first 10 days after surgery. The study will also look at how often patients still need extra pain treatments, such as an epidural, and whether their average daily pain scores are lower. Another important question is whether the treatment can help shorten the amount of time patients need to stay in the ICU. About 148 people from several hospitals will take part in the study. Everyone who joins the study will be followed for one year after their transplant to monitor their recovery and any long-term effects of the treatment.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Adults ≥18 years of age\n* Undergoing double lung transplantation via bilateral thoracotomies or clamshell incision\n\nExclusion Criteria:\n\n* Multi-organ transplant recipients\n* Redo lung transplant recipients'}, 'identificationModule': {'nctId': 'NCT07281118', 'briefTitle': 'Intercostal Cryoanalgesia in Double Lung Transplant Recipients', 'organization': {'class': 'OTHER', 'fullName': 'University of California, Los Angeles'}, 'officialTitle': 'Intercostal Cryoanalgesia in Double Lung Transplant Recipients', 'orgStudyIdInfo': {'id': 'IRB-24-6029'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Treatment Arm', 'description': 'Patients will be treated intra-operatively with Atricure CryoSPHERE MAX Probe to 2', 'interventionNames': ['Device: Atricure CryoSPHERE MAX Probe']}, {'type': 'NO_INTERVENTION', 'label': 'Usual Care', 'description': 'No treatment intra-operatively'}], 'interventions': [{'name': 'Atricure CryoSPHERE MAX Probe', 'type': 'DEVICE', 'otherNames': ['Cryotherapy'], 'description': 'Patients will be treated intra-operatively with Atricure CryoSPHERE MAX Probe to 2 intercostal spaces above and below the thoracotomy incision for 1 minutes for each application during their double lung transplant procedure.', 'armGroupLabels': ['Treatment Arm']}]}, 'contactsLocationsModule': {'locations': [{'zip': '94143', 'city': 'San Francisco', 'state': 'California', 'country': 'United States', 'facility': 'University of California San Francisco', 'geoPoint': {'lat': 37.77493, 'lon': -122.41942}}, {'zip': '76706', 'city': 'Waco', 'state': 'Texas', 'country': 'United States', 'facility': 'Baylor University', 'geoPoint': {'lat': 31.54933, 'lon': -97.14667}}], 'centralContacts': [{'name': 'Steven Stokes', 'role': 'CONTACT', 'email': 'sstokes@mednet.ucla.edu', 'phone': '310-206-7436'}, {'name': 'Jenny Lester, MPH', 'role': 'CONTACT', 'email': 'jlester@mednet.ucla.edu', 'phone': '310-794-9728'}], 'overallOfficials': [{'name': 'Abbas Ardehali, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'University of California, Los Angeles'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO', 'description': 'Summary data and results will be shared.'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'University of California, Los Angeles', 'class': 'OTHER'}, 'collaborators': [{'name': 'AtriCure, Inc.', 'class': 'INDUSTRY'}], 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Professor of Surgery and Medicine', 'investigatorFullName': 'Abbas Ardehali, MD', 'investigatorAffiliation': 'University of California, Los Angeles'}}}}